Researchers have announced a breakthrough on a non-hormonal compound known as Adjudin. When injected as an attachment to a modified hormone that seeks out the testes, a low dose is a safe and effective contraceptive in rats. However, another promising drug, miglustat, has failed to make the leap from mice to men.
Baroness Llora Finlay of Llandaff, professor of palliative medicine and chronic pain at the Velindre NHS trust, Cardiff, is presenting this year?s Marsden Lecture at the Royal Free. Baroness Finlay will speak on ?Quality at the end of Life? in a lecture on Thursday 16 November.
The survival of lung cancer patients increases by up to 92% of cases, within ten years of being diagnosed, when annual preventative low-dose radiation CAT screening is carried out. This is the conclusion of the International Early Lung Cancer Action Programme (IELCAP) in which the only Spanish-based centres taking part were the University Hospital and the Centre for Research into Applied Medicine (CIMA), both part of the University of Navarre.
On 15 November, the World Health Organization (WHO) and its partners will officially launch the first ever International Medical Products Anti-counterfeiting Taskforce (IMPACT) and unveil the global plan to combat counterfeit medical products.
Natural compounds derived from a sea anemone extract and a shrub plant have been found to block the autoimmune disease response in type-1 diabetes and rheumatoid arthritis, according to University of California, Irvine researchers.
“Medicine alone is not enough to get you through cancer,” comments Linda Dibblee, breast cancer survivor and winner of the 2006 Lilly Oncology on Canvas International Art Competition and Exhibition. “You have to stay strong and positive through even the darkest times. Having a channel through which you can release your feelings can help you find strength that you never knew you had. For me, painting became my way of expressing all my thoughts, hopes and frustrations, and I truly believe it played a part in helping me beat cancer.”
Significant errors in insulin dose can result when blood glucose meters are miscoded according to new clinical study. When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications, according to findings of a new study presented at the Sixth Annual Diabetes Technology Meeting in Atlanta, Georgia.
Novartis announced today that Prexige? (lumiracoxib), an oral selective COX-2 inhibitor anti-inflammatory drug, has been cleared for approval in the European Union as a new treatment option for patients suffering from osteoarthritis. This is the most common form of arthritis and a leading cause of chronic pain[2].
Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai’s Zhangjiang Hi-Tech Park that will become an integral part of the Group’s global research and development network.
Scientists at Children’s Hospital of Pittsburgh of UPMC have identified a protein that is critical to the development of inflammation during lung infection in patients with cystic fibrosis. The identification of this protein, called interleukin-23, is an important finding that gives researchers a specific target for developing new therapies.